Discover advocacy materials, latest data, and practical guidance from the Measles & Rubella Partnership for those working in or interested in immunization.
Annual Reports
The Measles & Rubella Partnership tracks and records its progress in the world. Below are some of the reports from years past that can help give an idea on the magnitude of success which the initiative has reached.
Download 2024 ReportMore Reports
Annual Report 2020
Download 2020 Report
Annual Report 2019
Download 2019 Report
Annual Report 2018
Download 2018 Report
Annual Report 2017
Download 2017 Report
Annual Report 2016
Download 2016 Report
Annual Report 2015
Download 2015 Report
Annual Report 2014
Download 2014 Report
Annual Report 2013
Download 2013 Report
Annual Report 2012
Download 2012 Report
Annual Report 2011
Download 2011 Report
Annual Report 2010
Download 2010 Report
Annual Report 2009
Download 2009 Report
Annual Report 2008
Download 2008 Report
Annual Report 2007
Download 2007 Report- Measles & Rubella Strategic Framework 2021-2030 updated Jan. 2026
- Measles & Rubella Strategic Framework 2021-2030
- MR Research Survey Report 2017
- MRI Research Prioritization Report
- Measles Rubella Outbreak Response Fund Standard Operating Procedure
- Global Measles and Rubella Strategic Plan 2012-2020
- Measles and Rubella Global Strategic Plan 2012-2020 Midterm Review
- Financial Resource Requirements (FRR)
- MRI Investment Case
Progress Reports
Below are reports and links on the Measles and Rubella Partnership's progress in reducing measles mortality.
Policy and Strategy
Find links to relevant WHO position papers, the current and previous global and regional Strategic Plans for measles, rubella and immunization and SAGE reports.
Measles and Rubella Strategic Plans – Newest
- Measles and Rubella Operational Strategy 2026-2030
- Measles Outbreak Strategic Framework 2026-2030
- Measles & Rubella Strategic Framework 2021-2030
Position Papers
- WHO Position Paper on Measles Vaccine
- WHO/UNICEF Joint Statement on Strategies to Reduce Measles Mortality
- WHO/UNICEF Joint Statement on Reducing Measles Mortality in Emergencies
- WHO Position Paper on Rubella Vaccine
Global Immunization Plans
Meeting Presentations
The Measles and Rubella Partnership has spent much effort fighting for its cause by means of widespread education. One of the main mediums used is Power Point presentations. Below you will find some of the Partnership's archived presentations.
Download 2024 Advocacy in Action Meeting- Egypt- Path to achieving Rubella and CRS elimination
- Gavi-UNICEF joint session – Using Immunisation to strengthen PHC
- Global Measles and Rubella Lab Network Perspective
- Global Polio Eradication Perspective – Overview of Polio Integration
- Measles & Rubella Strategic Framework – Revising Monitoring & Evaluation Framework
- Measles and Rubella surveillance Experience from the Tanzania National Public Health Laboratory
- Micro-Array Patch Introduction
- Not Business as Usual – Why Measles & Rubella are Important Now
- Operationalize Measles as a Tracer
- Opportunities to use communication to drive collective action toward M&RP priorities
- Social Mobilization & How Communities Make Impact
- Story from Field – 5-Point Plan
- Story from the Field- An Innovation to Address Inequalities – Microarray Patches
- Successful Communications Strategies to Reach Zero Dose Children in India
- Using Immunization to Strengthen Primary Health Care
- Celebrating the 50th Anniversary of the Expanded Program on Immunization
- HOA Video – UNICEF – Catherine Russel
- American Red Cross Gail McGovern
- The Gates Foundation, Chris Elias
- U.S. CDC, Mandy Cohen
- Gavi, the Vaccine Alliance, Aurelia Ngyuen
- UN Foundation, Elizabeth Cousens
- UNICEF, Catherine Russell
- WHO, Tedros Adhanom Ghebreyesus
- Dr Hinman Lifetime Achievement Acceptance Speech
- DR. Koplan Keynote Speech
- Ms. Henrietta Fore, Executive Director, UNICEF (video)
- WHO Global overview of progress and challenges
- PAHO- Response in the Americas to measles importations
- Colombia Outbreak response in a setting of humanitarian need (2)
- Philippines Red Cross Responding to the 2019 Measles Outbreak in the Philippines
- Vaccinations Science Controversy and Public Trust The Story of Clark County 2019 Measle Outbreak
- Madagascar Measles outbreak increased partner support and a focus on strengthening routine immunization
- Dr. Haldar, India
- Pulse Check US
- Outbreaks Summary of lessons learnt and the vision for the future final
- Viewpoint from the CDC Director Dr. Robert Redfield
- A rapid diagnostic test for measles Can it transform surveillance
- Creating the MR post 2020 framework
- Laying the Foundation for a Successful Future
- Gavi- A vision forward
- De Swart Immuno Amnesia
- Communications Panel – Measles Moves Fast, Our External Communications Should Too
- Promoting Vaccination Demand
- Family Perspective – My Familys Story Living with Congenital Rubella Syndrome
- Moving the Needle on Capitol Hill Grassroots Advocacy
- Measles and Rubella Vaccinations by Microneedle Patch
- American Red Cross 5 Point Plan
- American Academy of Pediatrics Global Immunization Champions project
- Best Practice Guidance Respond Vocal Vaccine Deniers
- CDC Measles-Rubella Elimination Team
- Civil society support in MR elimination to date
- Global Status of Measles and Rubella Elimination Activities
- Introduction to the Gavi CSO Platforms Project
- Role of Indonesia Pediatric Society in Immunization
- Role of Kenya Paediatric Association in Immunizations
- Role of Paediatric Association of Nigeria in Immunizations
- Role of Philippine Pediatric Society in Immunizations
- What we know about vaccine hesitancy and the role of pediatric societies
- MRI Pediatric Societies Summary and Next Steps
- Conducting a Mass Measles Campaign Among Internally Displaced Populations in Northeast Nigeria
- From Campus to Capitol Hill
- Gavi, the Vaccine Alliance
- India Country Experience
- India MR Communication Strategy
- Keynote Address – Dr. Alan Hinman
- Measles and Rubella Vaccination Using a Microneedle Patch
- Measles Containing Vaccines, Overview of Supply Through UNICEF
- Midterm Review Report
- MR Surveillance in India
- https://s3.amazonaws.com/wp-agility2/measles/wp-content/uploads/2017/09/Risks-and-Opportunities-of-Transitioning-Polio-Resources-to-Support-MR-Elimination.pptx
- Surveillance and Why it is Important
- Can House to House Social Mobilization Support Identification of Missed Children for Routine Immunization
- Characterizing the Health and Financial Costs of Measles and Rubella
- Dr Jadhav – Opening Comments
- Opportunities in the Second Year of Life
- Philippines-Strengthening Routine Immunization in Urban Poor Communities
- Red Cross Volunteers Experience
- Story From the Field – Malawi GIS
- The Role of Pediatricians and National Pediatric Societies
- Global Measles and Rubella Update
- Global Measles Rubella Laboratory Network (GMRLN) update
- The New Gavi Measles Strategy
- Findings and Recommendations from the Midterm Review
- The Experience with the M&RP Outbreak Response Fund Lessons Learned
- Recent Outbreaks WPRO
- Recent Outbreak AFRO
- Recent Outbreaks EMRO
- Midterm Review Recommendations on Outbreak Response
- Updates from the Regional MR Laboratory Networks WPR
- Updates from the Regional MR Laboratory Networks SEAR
- Updates from the Regional MR Laboratory Networks EMR
- Updates from the Regional MR Laboratory Networks EUR
- European Regional Presentation
- Southeast Asia Regional Presentation
- Western Pacific Regional Presentation
- Eastern Mediterranean Regional Presentation
- Americas Regional Presentation
- Africa Regional Presentation
- Cross Cutting MR and RI Priorities
- Overview of Second Year of Life
- India Experience with Measles 2nd Dose and DPT Booster in 2nd Year of Life
- Strengthening the 2YL Platform and Men A Introduction Plan in Ghana
- Recording and Monitoring in the Second Year of Life
- Dose Per Container Partnership
- MCV Wastage
- Lessons Learned and Key Factors Affecting SIA Quality
- Micro-Planning to Ensure SIA Reaches the Unvaccinated
- SIA Readiness Assessment Tool Uganda Experience
- Piloting of Mobile Technologies for Rapid Convenience Monitoring in the Nepal Measles Rubella Campaign
- Post SIA Coverage Survey New WHO Vaccination Coverage Cluster Survey Reference Manual
- Challenges and Opportunities Associated with the New SIA Coverage Survey Guidelines and Practical Issues
- Updates from the Regional MR Laboratory Networks AFR
- Updates from the Regional MR Laboratory Networks AMR
- Measles and Rubella IgM Proficiency Testing
- Molecular EQA for GMRLN Year Two
- Process and Results of First Molecular PT Exercise in EUR
- Introduction and Comments on Measles Genotype Distribution and Lesson Learned
- Overview of Measles and Rubella Genotypes and MeaNS and RubeNS Update
- Multiple Genotypes Circulating in Russian Federation
- Measles Genotype Diversity in SEAR
- Whole Genome Sequencing for Measles a Case Study in Brazil
- Evolution of Rubella Viruses During Persistent Infection
- Evolution of Rubella Viruses Following Long Term Endemic Circulation
- Progress on the Development of the Revised Laboratory Manual
- N.E.W. Next Generation, Extended Window and Whole Genome Sequencing Working Group
- Vaccine Specific RT PCR for Measles MeVA
- Multiplex Bead Assay Multiplex Immuno Assay
- National Institute of Infectious Diseases Update
- Poliovirus Containment
- Global Health Security Activities
- Africa Regional Presentation
- Measles and Rubella Surveillance Roadmap
- DRC Challenges with Multiple Surveillance Systems
- How the Philippines Overcame the Surveillance Challenges Elicited by the 2014 Measles Outbreak
- Measles and Rubella Surveillance in the time of Zika
- CRS Burden Estimates
- Measles and Rubella Serosurveys
- Serosurveillance
- Innovations Measles Programmatic Risk Assessments
- Disappearance of Measles Genotypes
- Next Generation and Extended Sequencing Working Group for Measles and Rubella
- Developing Point of Care Tests for Measles Surveillance
- Mircroneedle Patches An Emerging Vaccine Delivery Technology to Achieve High
- Coverage for Measles and Rubella Vaccines
- From the Field: Ms. Sylvia Khamati, Kenya Red Cross Society
- Sustaining the Gains in Mortality Reduction and Reaching Milestones on the Way Toward Elimination, Dr. Peter Strebel, WHO
- Achieving Success in Rubella Elimination: Dr. Jon Andrus, Sabin Vaccine Institute
- What is the Role of M&RP?
- Story From the Field: Dr. Jennifer Zipprich, California Department of Public Health
- Stakeholder Consultation on the Mid-Term Review and the Way Forward
- M&RP Financial Resource Requirements: Dr. Yodit Sahlemariam, UNICEF
- Workshop on Communicating for Impact
- Updates from Gavi, The Vaccine Alliance, Stefano Malvoti, Gavi
- Status of Global Poliomyelitis Eradication Initiative Legacy Planning and Implementation, Dr. Steve Cochi, CDC
- Country Viewpoint, Dr. Jeff McFarland, WHO on behalf of Ministry of Health India
- Country Viewpoint, Dr. Nada Ahmed, Ministry of Health Sudan
- Economics of Measles and Rubella: Dr. Kim Thompson, Kid Risk
- Margo Jacobs, Shot@Life
- Erin Hohlfelder, ONE
- Mona Aryal, Nepal Red Cross Society
- Story from the Field: Ms. Julie Boonprasarn, Lions Clubs International Foundation
- Story from the Field: Mr. Francis Kateh, Deputy Health Minister & Chief Medical Officer, Liberia
- Implementation of MR TAG Meeting 2013 Recommendations
- Global Measles and Rubella Update
- Regional Measles Elimination Program Updates
- Invalid MCV1 Doses – How Big A Problem?
- MCV2 Introduction and the Second Year of Life Contact
- MR Introduction and Rubella Epidemiology in AFRO
- Measles Vaccination in MSF Context
- Discussion Points Day One
- CRS Surveillance in AFR
- Measles/ MR Supplemental Immunisation Activities Quality
- Update on Measles & Rubella Surveillance in the WHO African Region
- The Performance of the Regional Laboratory Network
- Polio Legacy Planning Discussion
- 2013-2014 M&RP Annual Review
- 2014 Finance Update
- AFRO Region Update
- Communications Presentation
- Country Update – Somalia
- EMRO Region Update
- M&RP Fundraising and Outreach Session
- Outbreak Response Fund Presentation
- SEARO Region Update
- Advocacy Break Out Sessions
- AMRO Region Update
- Country Update – Ghana
- Country Update – India
- Country Update – Nigeria
- EURO Region Update
- Global Rubella Update
- Routine Immunization Overview
- Routine Immunization Strengthening in Tanzania and Uganda
- WPRO Region Update
- The Golden Anniversary of Measles Vaccine
- Funding Update 2013-2015
- Progress in Creating a World Free of Measles & Rubella
- Young People Helping Young People
- Communication Updates
- EMRO: Focus on Response to Humanitarian Disaster
- AFRO: Focus on Response to Measles Resurgence
- EURO: Focus on Advocacy and Communication Response to Measles and Rubella Resurgence
- Social Mobilization in Practice
- Tools for Strengthening SIAs and Routine Immunization
- Country Report: Rwanda
- Engaging Government and Civil Society to Achieve the Elimination
- WPRO: Final Push to Eliminate Measles and Control Rubella
- SEARO: Focus on Plans to Eliminate Measles
- Global Overview of Measles & Rubella
- Road Map to Achieving Goals
- The Measles & Rubella Partnership: Preparing for the Next Decade
- Priorities in the Measles and Rubella Research Agenda
- Supporting the Measles Rubella Initiative Globally, Impacting Communities Locally
- LDS Immunization Initiative
- GAVI Support for Measles and Rubella Immunization
- Funding Update: Current Situation and Future Prospects
- Eliminating Measles: Western Pacific Region in Action
- Progress towards Measles Elimination China, 2012
- Progress on SIAs and MCV2 introduction in India
- Measles mortality reduction in SEAR
- Using Measles SIAs to Strengthen Routine Immunization
- India Routine Immunization & Measles SIA synergies assessment
- African Region – priorities to reach the 2020 measles elimination goal
- Measles and rubella outbreaks in WHO Region of Europe
- Measles Vaccination in Emergency Setting
- Validation of measles & rubella elimination, challenges in Ecuador and Haiti
- Monitoring the impact of vaccination on rubella and CRS
- House to House Mobilization for successful measles SIAs: SITREP after five years in Africa
- Reaching missed kids
- Surveillance for Measles and Rubella is Provided by the WHO Global Measles and Rubella Laboratory Network Competent and Sustainable Global Laboratory
- Measles and Rubella investment cases: Stakeholder analysis and update
- Hong Kong Training Workshop, 2010
- Measles & Rubella Partnership Advocacy & Communication
- Mass Measles Campaign (2012)
- TRCS Experience on Social Mobilization for Integrated Measles Campaign of 2011
- URCS Mass Measles Social Mobilization Campaign
- Decade of Vaccines – How can measles deliver?
- Global measles and rubella technical update
- What happened at the Strungmann Forum?
- Proceedings of the SAGE Working Group on Rubella
- Recommendations from the 2010 Global LabNet Meeting
- Innovation and new technologies for measles eradication
- Measles vaccination: Alternative delivery methods
- Highlights and priorities – EURO
- Highlights and priorities – WPRO
- Progress toward measles elimination in China
- Highlights and priorities – EMRO
- Highlights and priorities – SEARO
- Update on the Implementation of Measles Second Dose in India
- Progress and challenges in Bangladesh
- Highlights and priorities – AFRO
- Measles outbreak in Malawi – Reasons and response
- Experience in Ethiopia in conducting best practices measles campaign
- Do we need a measles vaccine stockpile for more effective measles outbreak response?
- Outline of the Measles Strategic Plan 2011-2020
- Monitoring progress toward the coverage and disease incidence targets
- New model for estimating progress towards the 2015 mortality reduction goal
- Update on the global supply of measles and measles-rubella vaccine
- Advocacy across the Measles Initiative
- Global Overview of Measles
- African Region Update
- Southeast Asia Region Update
- European Region Update
- Western Pacific Region Update
- Eastern Mediterranean Region Update
- East and Southern Africa Outbreaks
- Measles Outbreak & Response 2009-2011: South Africa
- Challenges in Measles Outbreak Response: MSF Perspectives
- Updated 2011 WHO Rubella Vaccine Position Paper and Implications for Regions and Countries
- Achieving and Sustaining Measles and Rubella Elimination
- Rubella Epidemiology in Africa
- Routine Immunization: The Fifth Child Perspective
- MCV2 Introduction
- Global Measles and Rubella Strategic Plan
- Measles Initiative Management and Financing
- Economic Analysis of Measles Mortality Reduction and Eradication
- Implementing a Best Practice: Ethiopia’s Experience
- Measles Elimination in Pakistan
- Update on Measles Mortality Reduction in India
- American Red Cross Domestic Outreach
- Lions Club International
- LDS Church and Red Cross Social Mobilization
- Sabin Vaccine Institute
- AMMRIRIA Update
Partners
Find links to founding partners' measles and rubella websites and other relevant sites below.
World Health Organization Regions
Guidelines
- Immunization Coverage Cluster Survey Reference Manual
- Making Surveillance Work
- Manual for the Laboratory-based Surveillance of Measles, Rubella, and Congenital Rubella Syndrome
- Mass Measles Campaigns Reporting Adverse Effects Following Immunization
- Best Practices for Measles Surveillance
- Surveillance for Adverse Efforts Following Immunization Field Guide
- Treating Measles in Children
- Surveillance Standard
- Establishing and Strengthening Immunization in the Second Year of Life (2YL)
- Checklist on Gender and Immunization Demand Generation
- Gender Immunization Demand Final Report C3
- Integrating Gender in Immunization Demand case studies
- Field Aid 1 – Promoting Vaccination on Social Media
- Field Aid 2 – Second Year of Life Communication
- Field Aid 3 – Community Engagement & Dialogue
- Field Aid 4 – Media Approaches & Actions
- Field Aid 5 – Leveraging Resources & Partnerships
- Field Aid 6 – Evidence Driven Advocacy & Asks
- Field Aid 7 – Communication Monitoring & Evaluation
- 1 Guide Pratique Promotion de la Vaccination sur les reseaux sociaux
- 2 Guide pratique Communication au cours de la deuxieme annee de vie
- 3 Guide pratique mobilization et Dialogue Communautaires
- 4 Guide pratique Approches et Actions des Medias
- 5 Guide pratique Tirer Parti des Ressources et des Partenariats
- 6 Guide pratique Plaidoyer et Demandes Fondees sur des Donnees Probantes
- 7 Guide pratique Suivi et Evaluation de la Communication
- 1 UNICEF Communications Field Guides – Arabic
- 2 UNICEF Communications Field Guides – Arabic
- 3 UNICEF Communications Field Guides – Arabic
- 4 UNICEF Communications Field Guides – Arabic
- 5 UNICEF Communications Field Guides – Arabic
- 6 UNICEF Communications Field Guides – Arabic
- 7 UNICEF Communications Field Guides – Arabic
- MR Communication Guide Africa
- Measles and Measles-Rubella (MR) Vaccine Five-dose Vial Fact Sheet
African Region
Americas Region
European Region
Western Pacific Region
Additional Tools
- SIA Readiness Assessment Tool
- SIA Operating Procedures
- UNICEF E-Learning – High-Quality Measles and Rubella SIAs eLearning Program.
*If you are not a member of UNICEF, register as a "guest" at the bottom of the login page. Once logged in, enter "High Quality Measles and Rubella SIAs" in the Agora search window to locate the course.
Prelude Version 2.3.2